# A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness

> **NCT02271854** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 102 (actual)

## Conditions studied

- Muscle Soreness

## Interventions

- **DRUG:** Diclofenac sodium gel 1%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02271854
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2016-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02271854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02271854, "A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02271854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*